Abercrombie & Fitch: Fade The Rally - Outsized Market Rotation Meets Mixed Fundamentals (Downgrade)

Abercrombie & Fitch has proven to be a beneficiary of the ongoing market rotation from AI to value-oriented stocks, as ...

Truist Maintains Hold on Zebra Technologies (ZBRA) While Lowering PT Amid Scrutiny of 2026 Demand

Looking toward the end of the year, Zebra Technologies Corporation (NASDAQ:ZBRA) forecasts sales growth between 8% and 11% ...

Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook

Merck (MRK) looks undervalued amid 2028 Keytruda patent fears—strong Q3 results, pipeline wins, and 12x P/E suggest upside.